Avantor (AVTR) Stock Price, News & Analysis

Company Overview

Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers.

The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.

Avantor traces its history to J.T. Baker Chemical Company, founded in 1904, and serves customers across international markets. Its business focuses on helping organizations source and manage the specialized materials and services needed for research, development and manufacturing.

Key Stats

• Today's Range: $15.59 to $15.90
• 50-Day Range: $14.64 to $17.32
• 52-Week Range: $7.26 to $17.45
• Volume: 5.54 million shs
• Average Volume: 10.92 million shs
• Market Capitalization: $10.68 billion
• P/E Ratio: 18.99
• Dividend Yield: N/A
• Price Target: $14.77
• Consensus Rating: Hold

Avantor Stock Analysis - MarketRank™

Avantor scored higher than 64% of companies evaluated by MarketBeat, and ranked 452nd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Avantor has received a consensus rating of Hold. The company's average rating score is 2.06, and is based on no strong buy ratings, 2 buy ratings, 13 hold ratings, and 1 sell rating.

Downside Risk

Avantor has a consensus price target of $14.77, representing about 6.3% downside from its current price of $15.76.

Amount of Analyst Coverage

Avantor has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 7.32%

Earnings Growth

Earnings for Avantor are expected to grow by 7.32% in the coming year, from $0.82 to $0.88 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Avantor is 18.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.24.

Price to Earnings Ratio vs. Sector

The P/E ratio of Avantor is 18.99, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.15.

Price to Earnings Growth Ratio

Avantor has a PEG Ratio of 7.04. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Avantor has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.98% of the float of Avantor has been sold short.

Short Interest Ratio / Days to Cover

Avantor has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Avantor has recently decreased by 22.35%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Avantor does not currently pay a dividend.

Dividend Growth

Avantor does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 1.10

News Sentiment

Avantor has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Avantor this week, compared to 7 articles on an average week.

MarketBeat Follows

3 people have added Avantor to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Avantor insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.28% of the stock of Avantor is held by insiders.

Percentage Held by Institutions

95.08% of the stock of Avantor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 10/28/2026
• Today: 11/11/2026
• Investor Day 2026: 12/08/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NYSE:AVTR
• CIK: 1722482
• Web: www.avantorsciences.com
• Phone: (610) 386-1700
• Fax: N/A
• Employees: 13,500
• Year Founded: 1904

Price Target and Rating

• Average Price Target for Avantor: $14.77
• High Price Target: $18.00
• Low Price Target: $7.00
• Potential Upside/Downside: -6.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.06
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.50
• Trailing P/E Ratio: 18.99
• Forward P/E Ratio: 17.91
• P/E Growth: 7.04
• Net Income: -$530.20 million
• Net Margins: 5.08%
• Pretax Margin: 4.75%
• Return on Equity: 9.79%
• Return on Assets: 4.74%

Debt

• Debt-to-Equity Ratio: 0.63
• Current Ratio: 1.89
• Quick Ratio: 1.27

Sales & Book Value

• Annual Sales: $6.55 billion
• Price / Sales: 1.63
• Cash Flow: $1.53 per share
• Price / Cash Flow: 10.28
• Book Value: $8.61 per share
• Price / Book: 1.83

Miscellaneous

• Outstanding Shares: 677,620,000
• Free Float: 675,719,000
• Market Cap: $10.68 billion
• Optionable: Optionable
• Beta: 0.95